Retrospective evaluation of risk determinants in prodromal period with a group of schizophrenia patients

被引:3
|
作者
Cakmak, Soner [1 ]
Karaytug, Mahmut Onur [1 ]
Bal, Ufuk [2 ]
Tamam, Lut [1 ]
Tasdemir, Ali [1 ]
机构
[1] Cukurova Univ, Fac Med, Dept Psychiat, Adana, Turkey
[2] Askim Tufekci Hosp, Psychiat Clin, Adana, Turkey
来源
CUKUROVA MEDICAL JOURNAL | 2016年 / 41卷 / 03期
关键词
Schizophrenia; risk factors; psikoz;
D O I
10.17826/cukmedj.234960
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: This study aims to investigate the significance of risk determiners in the occurence of schizophrenia. and the link between the severity of determiners and the duration to full-blown schizophrenia. Material and Methods: Patients older than 18 years old, diagnosed with schizophrenia are included in our study. SOPS (Scale of Prodromal Symptoms) is applied to determine the risk of schizophrenia prodromal period, scale scores are calculated and patients are classified in accordance to risk syndrome criteria defined in SIPS (Structured Interview for Prodromal Symptoms). Results: Prodromal symptoms are detected in 68 of 100 patients. Of those 68 patients, 47 met the criteria for Attenuated Positive Prodromal Syndrome (APPS), 20 met the criteria for Brief Intermittent Psychotic Syndrome (BIPS), 24 met the criteria for Genetic Risk and Deterioration Syndrome (GRDS), 67 met the criteria for Psychotic Syndrome (PS), 44 met the criteria for Attenuated Psychosis Syndrome (APS) in DSM-5. Grandiosity, perceptual abnormalities/hallucinations, poverty of thought, deterioration in a role functioning, peculiar behaviour and appearance, decreased tolerance to normal stress are manifested to be meaningful in APPS, Conclusion: It's clear that prodromal symptoms are increasing markedly the odds of psychosis and schizophrenia occurance in respect to normal population. Nevertheless, further customization and elaboration of risk determining criteria, searching and displaying neurobiological risk factors among criteria, will help to reliably identify risk groups and detect disorder in prodromal period.
引用
收藏
页码:437 / 446
页数:10
相关论文
共 50 条
  • [21] THE EVALUATION OF NSAIDS IN THE PERIOPERATIVE PERIOD: A RETROSPECTIVE ANALYSIS OF BARIATRIC SURGERY PATIENTS
    Nair, Singh
    Tseng, Victor
    Delphin, Ellise
    Tucker, Annelisa
    ANESTHESIA AND ANALGESIA, 2018, 126 (04): : 401 - 401
  • [22] Orienting of attention in unmedicated patients with schizophrenia, prodromal subjects and healthy relatives
    Gouzoulis-Mayfrank, Euphrosyne
    Balke, Maryam
    Hajsamou, Soulmaz
    Ruhrmann, Stephan
    Schultze-Lutter, Frauke
    Daumann, Joerg
    Heekeren, Karsten
    SCHIZOPHRENIA RESEARCH, 2007, 97 (1-3) : 35 - 42
  • [23] Prodromal symptoms of psychosis in first degree relatives of patients with schizophrenia.
    Heinimaa, M. L. A.
    Huttunen, J.
    Ristkari, T.
    Svirskis, T.
    Korkeila, J.
    Plathin, M.
    Ilonen, T.
    McGlashan, Th. H.
    Hietala, J.
    Salokangas, R. K. R.
    SCHIZOPHRENIA RESEARCH, 2006, 86 : S84 - S84
  • [24] Gray matter loss in young relatives at risk for schizophrenia: Relation with prodromal psychopathology
    Bhojraj, Tejas S.
    Sweeney, John A.
    Prasad, Konasale M.
    Eack, Shaun M.
    Francis, Alan N.
    Miewald, Jean M.
    Montrose, Debra M.
    Keshavan, Matcheri S.
    NEUROIMAGE, 2011, 54 : S272 - S279
  • [25] Risk and protection in prodromal schizophrenia: Ethical implications for clinical practice and future research
    Haroun, N
    Dunn, L
    Haroun, A
    Cadenhead, KS
    SCHIZOPHRENIA BULLETIN, 2006, 32 (01) : 166 - 178
  • [26] Impaired prepulse inhibition of the startle reflex in patients with prodromal symptoms of schizophrenia
    Koev, I
    Cadenhead, KS
    SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 253 - 253
  • [27] Determinants for medication adherence in patients with schizophrenia
    Watanabe, H.
    Shirayama, Y.
    Iyo, M.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 168 - 168
  • [28] Electrocardiographic Evaluation of the Ventricular Arrhythmia Risk in Patients Diagnosed With Schizophrenia
    Ozsoy, Filiz
    Zorlu, Cagri
    Kaya, Suheda
    ALPHA PSYCHIATRY, 2021, 22 (02): : 85 - 89
  • [29] Incidence and cumulative risk of treated schizophrenia in the prenatal determinants of schizophrenia study
    Bresnahan, MA
    Brown, AS
    Schaefer, CA
    Begg, MD
    Wyatt, RJ
    Susser, ES
    SCHIZOPHRENIA BULLETIN, 2000, 26 (02) : 297 - 308
  • [30] Benzodiazepine Use and Risk of Mortality Among Patients With Schizophrenia: A Retrospective Longitudinal Study
    Fontanella, Cynthia A.
    Campo, John V.
    Phillips, Gary S.
    Hiance-Steelesmith, Danielle L.
    Sweeney, Helen Anne
    Tam, Kwok
    Lehrer, Douglas
    Klein, Robert
    Hurst, Mark
    JOURNAL OF CLINICAL PSYCHIATRY, 2016, 77 (05) : E661 - E667